General
Preferred name
NORETHYNODREL
Synonyms
Lynestrol ()
NSC-15432 ()
Enidrel ()
noretynodrel ()
SC-4642 ()
P&D ID
PD013229
CAS
8015-30-3
68-23-5
Tags
natural product
drug
available
Approved by
FDA
First approval
1961
Drug Status
approved
withdrawn
Max Phase
Phase 4
Drug indication
Progestin
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
298.19
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
0
cLogP
3.64
TPSA
37.3
Fraction CSP3
0.75
Chiral centers
5.0
Largest ring
6.0
QED
0.55
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
contraceptive
Target
PGR
MOA
progestogen hormone
ATC
G03FA09
Source data
